{"id":"esflurbiprofen","rwe":[{"pmid":"41729853","year":"2026","title":"Drug-induced upper gastrointestinal bleeding: A real-world pharmacovigilance study.","finding":"","journal":"PloS one","studyType":"Clinical Study"},{"pmid":"41303134","year":"2025","title":"Efficacy of NSAID Transdermal Patch for Postoperative Management in Total Knee Arthroplasty.","finding":"","journal":"Journal of clinical medicine","studyType":"Clinical Study"},{"pmid":"41068287","year":"2026","title":"Esflurbiprofen exerts a fast-onset antidepressant effect by blocking SERT-nNOS interaction.","finding":"","journal":"Acta pharmacologica Sinica","studyType":"Clinical Study"},{"pmid":"34529839","year":"2021","title":"Comparison of tissue pharmacokinetics of esflurbiprofen plaster with flurbiprofen tablets in patients with knee osteoarthritis: A multicenter randomized controlled trial.","finding":"","journal":"Biopharmaceutics & drug disposition","studyType":"Clinical Study"},{"pmid":"29760367","year":"2018","title":"[Pharmacological action and clinical outcome of newly developed NSAIDs patch, \"LOQOA(®) tape\"].","finding":"","journal":"Nihon yakurigaku zasshi. Folia pharmacologica Japonica","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Prostaglandin G/H synthase 2","category":"target"},{"label":"PTGS2","category":"gene"},{"label":"M02AA29","category":"atc"},{"label":"Active","category":"status"},{"label":"Osteoarthritis","category":"indication"},{"label":"Taisho Pharmaceutical Co., Ltd.","category":"company"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"Taisho Pharmaceutical Co., Ltd.","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=ESFLURBIPROFEN","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:21:56.138002+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:22:01.446584+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ESFLURBIPROFEN","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:22:02.010560+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Cyclooxygenase inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:22:03.089549+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL435298/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:22:02.742427+00:00"}},"allNames":"loqoa","offLabel":[],"synonyms":["loqoa","esflurbiprofen","TT-063"],"timeline":[{"date":"2015-09-28","type":"positive","source":"DrugCentral","milestone":"PMDA approval (Taisho Pharmaceutical Co., Ltd.)"}],"approvals":[{"date":"2015-09-28","orphan":false,"company":"Taisho Pharmaceutical Co., Ltd.","regulator":"PMDA"}],"brandName":"Loqoa","ecosystem":[{"indication":"Osteoarthritis","otherDrugs":[{"name":"aceclofenac","slug":"aceclofenac","company":""},{"name":"acetylsalicylic acid","slug":"acetylsalicylic-acid","company":"Endo Pharms"},{"name":"celecoxib","slug":"celecoxib","company":"Gd Searle"},{"name":"choline magnesium trisalicylate","slug":"choline-magnesium-trisalicylate","company":""}],"globalPrevalence":655000000}],"mechanism":{"target":"Prostaglandin G/H synthase 2","targets":[{"gene":"PTGS2","source":"DrugCentral","target":"Prostaglandin G/H synthase 2","protein":"Prostaglandin G/H synthase 2"}],"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Loqoa acts as a non-selective inhibitor of Prostaglandin G/H synthase 2, also known as COX-2, which is involved in the production of prostaglandins E2 and I2, key mediators of inflammation and pain."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/5060","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=ESFLURBIPROFEN","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ESFLURBIPROFEN","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:11:23.500940","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:22:04.355528+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"phenylbutazone","drugSlug":"phenylbutazone","fdaApproval":"1980-01-10","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"oxyphenbutazone","drugSlug":"oxyphenbutazone","fdaApproval":"1960-12-21","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"piroxicam","drugSlug":"piroxicam","fdaApproval":"1982-04-06","genericCount":18,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ketoprofen","drugSlug":"ketoprofen","fdaApproval":"1986-01-09","genericCount":7,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"naproxen","drugSlug":"naproxen","fdaApproval":"1976-03-11","genericCount":31,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ibuprofen","drugSlug":"ibuprofen","fdaApproval":"1974-09-19","patentExpiry":"Sep 30, 2029","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"diclofenac","drugSlug":"diclofenac","fdaApproval":"1988-07-28","patentExpiry":"Apr 23, 2030","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"meclofenamic acid","drugSlug":"meclofenamic-acid","fdaApproval":"1980-06-25","relationship":"same-class"},{"drugName":"flurbiprofen","drugSlug":"flurbiprofen","fdaApproval":"1986-12-31","genericCount":8,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"tolmetin","drugSlug":"tolmetin","fdaApproval":"1976-03-24","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"indomethacin","drugSlug":"indomethacin","fdaApproval":"1965-06-10","patentExpiry":"Apr 23, 2030","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"aceclofenac","drugSlug":"aceclofenac","fdaApproval":"","relationship":"same-class"}],"genericName":"esflurbiprofen","indications":{"approved":[{"name":"Osteoarthritis","source":"DrugCentral","snomedId":396275006,"regulator":"FDA","usPrevalence":null,"globalPrevalence":655000000,"prevalenceMethod":"curated","prevalenceSource":"Arthritis Res Ther, 2023 (PMID:36991481)"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"phenylbutazone","brandName":"phenylbutazone","genericName":"phenylbutazone","approvalYear":"1980","relationship":"same-class"},{"drugId":"oxyphenbutazone","brandName":"oxyphenbutazone","genericName":"oxyphenbutazone","approvalYear":"1960","relationship":"same-class"},{"drugId":"piroxicam","brandName":"piroxicam","genericName":"piroxicam","approvalYear":"1982","relationship":"same-class"},{"drugId":"ketoprofen","brandName":"ketoprofen","genericName":"ketoprofen","approvalYear":"1986","relationship":"same-class"},{"drugId":"naproxen","brandName":"naproxen","genericName":"naproxen","approvalYear":"1976","relationship":"same-class"},{"drugId":"ibuprofen","brandName":"ibuprofen","genericName":"ibuprofen","approvalYear":"1974","relationship":"same-class"},{"drugId":"diclofenac","brandName":"diclofenac","genericName":"diclofenac","approvalYear":"1988","relationship":"same-class"},{"drugId":"meclofenamic-acid","brandName":"meclofenamic acid","genericName":"meclofenamic acid","approvalYear":"1980","relationship":"same-class"},{"drugId":"flurbiprofen","brandName":"flurbiprofen","genericName":"flurbiprofen","approvalYear":"1986","relationship":"same-class"},{"drugId":"tolmetin","brandName":"tolmetin","genericName":"tolmetin","approvalYear":"1976","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT07307794","phase":"PHASE1","title":"To Evaluate the Adhesion of TK-254RX on Healthy Participants","status":"RECRUITING","sponsor":"Teikoku Seiyaku Co., Ltd.","startDate":"2026-01-19","conditions":["Healthy Participants"],"enrollment":90,"completionDate":"2026-03"},{"nctId":"NCT06866613","phase":"PHASE3","title":"Phase III Trial to Evaluate the Efficacy and Safety in Patients With Ankle Sprains.","status":"COMPLETED","sponsor":"Teikoku Seiyaku Co., Ltd.","startDate":"2025-03-31","conditions":["Ankle Sprains"],"enrollment":69,"completionDate":"2025-10-30"},{"nctId":"NCT06871046","phase":"PHASE3","title":"Phase III Trial to Assess the Safety and Efficacy of TK-254RX in Patients With Contusions","status":"COMPLETED","sponsor":"Teikoku Seiyaku Co., Ltd.","startDate":"2025-02-20","conditions":["Contusions"],"enrollment":221,"completionDate":"2025-10-01"},{"nctId":"NCT06870422","phase":"PHASE1","title":"To Assess the Effect of the Special Condition on the Pharmacokinetics and Tolerability of the Esflurbiprofen Topical System (EFTS) in Healthy Volunteers.","status":"COMPLETED","sponsor":"Teikoku Seiyaku Co., Ltd.","startDate":"2025-02-28","conditions":["Healthy"],"enrollment":28,"completionDate":"2025-04-14"},{"nctId":"NCT06823284","phase":"PHASE1","title":"To Assess the Bioavailability of TK-254RX in Comparison with Oral Flurbiprofen Tablets and the Adhesion of TK-254RX in Healthy Subjects","status":"COMPLETED","sponsor":"Teikoku Seiyaku Co., Ltd.","startDate":"2025-01-21","conditions":["Healthy"],"enrollment":26,"completionDate":"2025-02-24"},{"nctId":"NCT04908748","phase":"PHASE2","title":"Efficacy and Safety of Esflurbiprofen Hydrogel Patch in the Treatment of Local Acute Pain","status":"COMPLETED","sponsor":"Teikoku Seiyaku Co., Ltd.","startDate":"2021-05-20","conditions":["Soft Tissue Injuries","Contusions","Strains","Sprains","Bruises"],"enrollment":200,"completionDate":"2021-12-15"},{"nctId":"NCT02729207","phase":"PHASE2","title":"Proof-of-concept Study of NSAID Hydrogel Patch in Treatment of Acute Pain","status":"TERMINATED","sponsor":"Teikoku Seiyaku Co., Ltd.","startDate":"2016-07","conditions":["Ankle Sprain"],"enrollment":6,"completionDate":"2016-12-27"},{"nctId":"NCT03434197","phase":"PHASE3","title":"Safety and Efficacy of SFPP in Knee Osteoarthritis","status":"COMPLETED","sponsor":"Taisho Pharmaceutical Co., Ltd.","startDate":"2018-02-05","conditions":["Osteoarthritis Knee Pain"],"enrollment":313,"completionDate":"2021-01-11"},{"nctId":"NCT04505787","phase":"PHASE1","title":"S-flurbiprofen Bioavailability Trial to Compare a Newly Developed Patch vs. a Marketed Tablet","status":"COMPLETED","sponsor":"SocraTec R&D GmbH","startDate":"2020-07-24","conditions":["Comparative Bioavailability"],"enrollment":26,"completionDate":"2020-09-24"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"019240","UNII":"J5ZZK9P7MX","CHEBI":"CHEBI:42446","INN_ID":"5776","UMLSCUI":"C2825249","chemblId":"CHEMBL435298","ChEMBL_ID":"CHEMBL435298","KEGG_DRUG":"D10254","DRUGBANK_ID":"DB16159","PDB_CHEM_ID":"FLP","PUBCHEM_CID":"72099","IUPHAR_LIGAND_ID":"9420"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"present","companyName":"Taisho Pharmaceutical Co., Ltd.","relationship":"Current Owner"}],"publicationCount":5,"therapeuticAreas":["Immunology"],"atcClassification":{"source":"DrugCentral","atcCode":"M02AA29","allCodes":["M02AA29"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026","pmid":"41729853","title":"Drug-induced upper gastrointestinal bleeding: A real-world pharmacovigilance study.","journal":"PloS one"},{"date":"2025 Nov 15","pmid":"41303134","title":"Efficacy of NSAID Transdermal Patch for Postoperative Management in Total Knee Arthroplasty.","journal":"Journal of clinical medicine"},{"date":"2026 Mar","pmid":"41068287","title":"Esflurbiprofen exerts a fast-onset antidepressant effect by blocking SERT-nNOS interaction.","journal":"Acta pharmacologica Sinica"},{"date":"2021 Nov","pmid":"34529839","title":"Comparison of tissue pharmacokinetics of esflurbiprofen plaster with flurbiprofen tablets in patients with knee osteoarthritis: A multicenter randomized controlled trial.","journal":"Biopharmaceutics & drug disposition"},{"date":"2018","pmid":"29760367","title":"[Pharmacological action and clinical outcome of newly developed NSAIDs patch, \"LOQOA(®) tape\"].","journal":"Nihon yakurigaku zasshi. Folia pharmacologica Japonica"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"approved","companyName":"Taisho Pharmaceutical Co., Ltd.","companyId":"taisho-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"2015","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"JP","regulator":"PMDA","status":"approved","approval_date":"2015-09-28T00:00:00.000Z","mah":"Taisho Pharmaceutical Co., Ltd.","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":2,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:22:04.355528+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}